Genialis ResponderID to Use Xerna™ TME Panel to Improve Targeted Therapy Selection
Biomarker discovery platform will incorporate pan-cancer tumor microenvironment classifier [...]
Inhibrx Selects Genialis ResponderID™ for Clinical Optimization Study of INBRX-109
Machine Learning technology platform to be evaluated for potential [...]
Taking charge of your health future with wearables and AI with Harry Glorikian | Podcast #26
Welcome to Talking Precision Medicine — the podcast in [...]
Genialis AI platform speeds identification of biomarkers
Cancer trials that stratify patients using biomarkers increase their [...]
Genialis Debuts ResponderID™ for Clinical Biomarker Discovery
Genialis, a computational precision medicine company unraveling complex biology [...]
Genialis Innovates Machine Learning Solutions for Clinical Biomarker Discovery
Genialis, a leader in applied data science for the [...]
Real-Time Multiplexed Biomarkers: The Next Generation of Continuous Monitoring with Peter Vranes and Hitesh Mehta | Podcast #25
Welcome to the Talking Precision Medicine podcast. In this [...]
Fostering Patient Journeys Around the World with Angeli Möller | Podcast #24
Welcome to the Talking Precision Medicine podcast. In this [...]
Genialis Expands Support for Clinical Biomarker Discovery Platform
The addition of four new team members with specific [...]
Genialis Presents Updated Results on AI-Enabled, RNA-Based Pan-Cancer Biomarker Platform at AACR
Biomarker platform is among the first validated applications of [...]
